Immix Biopharma, Inc. IMMX Deferred Tax Assets Lease
Deferred Tax Assets Lease at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept IMMX:DeferredTaxAssetsLease.
The official record: Immix Biopharma, Inc.’s 10-K/A, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s deferred tax assets lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s deferred tax assets lease?
- Immix Biopharma, Inc. (IMMX) reported deferred tax assets lease of $29.67K in Q4 2025.
- What does deferred tax assets lease mean?
- This metric reflects the deferred tax asset arising from the accounting treatment of lease liabilities and right-of-use assets under current lease accounting standards. It represents the tax impact of temporary differences between the carrying amount of lease-related assets and liabilities and their tax bases. It is a component of the company's overall deferred tax position related to long-term contractual obligations.